Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASPEN-AVR: Tadalafil in Aortic Stenosis
NCT01272388Phase 4Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Jan 2011
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in aortic stenosis (AS) comparing Tadalafil with Placebo (2 arms). Primary endpoint: Kansas City Cardiomyopathy Questionnaire at 4 weeks. Started Jan 2011; status: terminated.
02
Drugs
tadalafil
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on NCT01272388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01272388.